Biotechnology companies apply biological science to develop products, services and technologies that address challenges in healthcare, agriculture, industry and environmental sustainability.
This category includes companies working on:
Browse 463 UK biotechnology companies below.
Tissue-level disease platform for endometriosis drug discovery
Cyclana Bio is a drug discovery company developing tissue-level therapeutics for endometriosis and women's health conditions. The company builds whole-tissue disease models using…
RNA sequencing liquid biopsy for cardiovascular and complex disease screening
MultiplAI Health is a Cambridge biotech developing a whole-blood RNA sequencing test for early screening of cardiovascular and other complex diseases. Its platform combines…
Integrated NGS assays for genomic profiling of haematological malignancies
Univ8 Genomics is a Belfast-based genomics diagnostics company developing targeted next-generation sequencing assays for the integrated clinical characterisation of haematological…
High-throughput iPSC reprogramming and stem cell drug discovery services
Oxford StemTech is a contract research company providing induced pluripotent stem cell (iPSC) reprogramming and drug discovery services using its proprietary platform. The…
AI-driven T-cell receptor discovery platform for solid tumour immunotherapies
Exogene is an Oxford biotech developing TCR-based immunotherapies for solid tumours. Its platform integrates generative AI, biophysical simulation, and high-throughput TCR-antigen…
TSG-6 protein therapeutics for inflammatory and degenerative disease
Link Biologics is a preclinical-stage biotechnology company developing protein therapeutics based on TSG-6, an endogenous human protein with anti-inflammatory and…
Therapeutics targeting lysosomal dysfunction in neurodegeneration
Endlyz Therapeutics is a preclinical-stage biotechnology company developing small molecule modulators to restore endo-lysosomal function in Parkinson's disease and related…
Clinical skin microbiome testing and multi-omic ingredient analysis platform
Sequential Skin is a biotechnology company providing non-invasive clinical microbiome testing and multi-omic analysis services to the personal care and pharmaceutical industries.…
Antibody engineering platform improving solid tumour drug penetration
Creasallis is a Cambridge-based biotechnology company developing engineering solutions to improve the efficacy of antibody-based cancer therapies. Its patented technology modifies…
AAV gene therapies for rare neurological diseases of childhood
BlackfinBio is a biotechnology company developing AAV-based gene therapies for rare neurodegenerative diseases of the central nervous system, with an initial focus on children.…
Gene therapy platform targeting paediatric solid tumours
Kindling Bio is a biotechnology company developing a gene therapy platform designed specifically for childhood cancers. The platform engineers a biological signal that renders…
Deep learning platform for small molecule drug discovery
CHARM Therapeutics is a clinical-stage biotechnology company applying 3D deep learning to small molecule drug discovery. Its proprietary platform uses protein-ligand co-folding…